Rh blood group D antigen (RhD) (RhD)

The Rh blood group D antigen (RhD) is a complex, multi-pass transmembrane protein expressed on the surface of human erythrocytes [UniProt: P18577]. It is the most immunogenic protein in the Rh blood group system and plays a critical role in maintaining the structural integrity of the red blood cell membrane by interacting with the cytoskeleton [PubMed: 11062247]. Beyond its structural role, RhD is part of a core complex involved in the transport of ammonium and potentially carbon dioxide, contributing to pH regulation and gas exchange [NCBI: Gene ID 6000]. In clinical medicine, the RhD antigen is the primary cause of hemolytic disease of the fetus and newborn (HDFN), which occurs when an Rh-negative mother produces antibodies against the RhD-positive red blood cells of her fetus [StatPearls: Rh Incompatibility]. Therapeutic management involves the administration of Rho(D) immune globulin, which provides passive immunization to prevent maternal alloimmunization [FDA: RhoGAM Label]. Furthermore, anti-D antibodies are utilized in the treatment of immune thrombocytopenic purpura (ITP) to induce a controlled hemolytic state that prevents the destruction of platelets by the spleen [StatPearls: Rho(D) Immune Globulin].

Other names

Rhesus factorRh factorRhDCD240DRh polypeptide 1Rh antigen

The primary mechanism of action for drugs targeting the RhD antigen, such as Rho(D) immune globulin, is antibody-mediated immune suppression (AMIS). By binding to RhD-positive red blood cells in the recipient's circulation, the exogenous antibodies facilitate the rapid clearance of these cells by the reticuloendothelial system before the host's immune system can recognize the antigen and mount an active immune response [StatPearls: Rh Incompatibility]. In the context of immune thrombocytopenic purpura (ITP), anti-D antibodies coat RhD-positive erythrocytes, which then saturate the Fc receptors on splenic macrophages; this competitive inhibition reduces the clearance of antibody-coated platelets, thereby increasing platelet counts [PubMed: 12114204].